Question · Q3 2026
Jonathan Goldman asked about the company's bookings growth expectations for the current year, considering various market dynamics. He also inquired about the areas for reinvestment of the upsized restructuring charges and whether the payback would be top-line or cost-focused. Finally, he asked for the FX impact on the sequential increase in SG&A.
Answer
Interim CFO Anne Cybulski stated that despite timing impacts in custom integration and moderated auto-injector orders, the year-to-date bookings performance is satisfactory, and the funnel remains healthy. CEO Doug Wright added that the pipeline is robust, and the outlook is effectively calibrated. Anne explained that the upsized restructuring is for efficiency, with reinvestment in innovation and growth areas like nuclear and life sciences, with operating leverage benefits primarily in fiscal 2027. Doug emphasized aligning investments with new therapies and energy form factors. Anne noted that the FX impact on SG&A was relatively proportionate to the top-line FX benefit.
Ask follow-up questions
Fintool can predict
ATS's earnings beat/miss a week before the call